Effects of riluzole on glutamatergic neurotransmission in the mammalian central nervous system, and other pharmacological effects

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 4, 1997, Pages 213-225

  Doble, Adam ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPROTECTIVE AGENT; RILUZOLE; SODIUM CHANNEL;

AMYOTROPHIC LATERAL SCLEROSIS; CENTRAL NERVOUS SYSTEM; EXCITATION; EXCITOTOXICITY; HYPOTHESIS; MAMMAL; NERVE DEGENERATION; NEUROTOXICITY; NEUROTRANSMISSION; REVIEW; SEDATION; SIGNAL TRANSDUCTION;

EID: 0030721634     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. +-evoked amino acid release in the ventral hippocampus of the rat in vivo. Br J Pharmacol 1995; 115: 116P.
2. Barbeito L, Chéramy A, Godeheu G, Desce JM, Glowinski J. Glutamate receptors of a quisqualate-kainate subtype are involved in the presynaptic regulation of dopamine release in the cat caudate nucleus in vivo. Eur J Neurosci 1990; 2: 304-311.